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ABSTRACT
DECREASING COST IN THE GI ENDOSCOPY SUITE BY
UTILIZING BEST SEDATION PRACTICES
by Casey Brianne Mancini
May 2017
Colorectal cancer is a leading cause of cancer death in the United States (Mandel
et al., 2008; Siegel, DeSantis, & Jemal, 2014). Because this lethal disease claims lives of
many people every year, more patients are undergoing screening colonoscopies, which
have greatly aided in decreasing the number of colorectal cancer deaths (Siegel et al.,
2014). The most common form of sedation for colonoscopies is moderate sedation with a
benzodiazepine and an opioid (Cohen, Hightower, Wood, Miller, & Aisenberg, 2004;
Lera dos Santos et al., 2013). However, sedation by anesthesia providers using propofol
is becoming more common and may aid in reducing recovery and discharge times from
the postoperative anesthesia care unit (PACU) as well as reducing overall costs. A
retrospective chart review (N=176; 88 in propofol group and 88 in benzodiazepine and
opioid group) was performed to determine if propofol sedation did reduce discharge
times and decrease overall costs for the patient. Patients included in this study underwent
colonoscopy, were ASA PS I or II, and between the ages of 18 and 55. Exclusion criteria
for this project were as follows: ASA PS III or IV, non-English speaking, pregnancy,
allergy to eggs, fentanyl, or midazolam, previous neurological deficit, patients scheduled
for colonoscopy and EGD in the same day, hospital inpatients undergoing colonoscopy,
and patients undergoing emergency procedures. A one tailed independent groups t-test
was performed on the mean time from procedure end until discharge time in minutes.
ii

The hypothesis that colonoscopy patients sedated with propofol would be discharged
faster than patients receiving a benzodiazepine and an opioid for sedation was accepted
(group propofol M= 80.99, SD= 15.36 and group benzodiazepine and opioid M= 84.58,
SD= 13.42, p= 0.05). A cost analysis revealed that sedation with propofol by anesthesia
providers was more costly. While propofol patients are discharged faster, moderate
sedation with a benzodiazepine and an opioid may be more cost efficient if the same
number of patients underwent the procedure, however the decreased time may permit
more revenue via greater number of cases performed. Interviews with providers after
presenting the findings revealed future stakeholder strategies for a practice change.
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CHAPTER I - INTRODUCTION
In the healthcare industry, today cost efficiency is extremely important.
Organizations detest wasting time, supplies, and other tangible and intangible resources.
Since colonoscopies are one of the most common procedures performed today, utilizing
the best sedation practice under which to perform colonoscopies is one-way healthcare
providers can increase both financial and time savings for the organization and the
patient.
Background and Significance
One of the most prevalent health issues today is colorectal cancer. Colorectal
cancer outcomes have improved from being the leading cause of cancer mortality in the
late 1940’s and early 1950’s and the second leading cause of cancer mortality less than
10 years ago to being the third leading cause of cancer mortality today (Mandel et al.,
2008; Siegel et al., 2014). Many factors such as diet, lifestyle changes, early detection,
and treatment options have contributed to the decreased incidence of this fatal disease
(Siegel et al., 2014). Because of the importance of early detection in colorectal cancer,
colonoscopies have effectively reduced the number of deaths (Mandel et al., 2008). In
2000, 19% of patients, ages 50 to 75 years, had a routine screening colonoscopy. This
percentage dramatically increased to 55% in 2010 among the same age range (Siegel et
al., 2014). Although considered a routine procedure, colonoscopies are not without
discomfort for the patient (Mandel et al., 2008).
To improve patient comfort and tolerance, colonoscopies and other endoscopic
procedures in the gastrointestinal (GI) suite are typically performed while the patient is
sedated. In a 2006 survey, more than 98% of colonoscopies in the United States were
1

performed under sedation (Lera dos Santos et al., 2013). Sedation practices range from
mild sedation to moderate (conscious) sedation to deep sedation to general anesthesia
(Lera dos Santos et al., 2013; McQuaid & Lane, 2008). Sedation serves several purposes
during endoscopic procedures, including keeping the patient comfortable, improving
efficiency of the procedure, and obtaining better quality results (Lera dos Santos et al.,
2013).
The most commonly utilized sedation regimen is the combination of a
benzodiazepine and an opioid for production of anxiolysis and analgesia (Cohen et al.,
2004; Lera dos Santos, et. al., 2013). This combination of drugs is used in over 75% of
endoscopic facilities in the United States (Lera dos Santos et al., 2013). The short halflife, ability to produce anterograde amnesia, and anxiolytic and sedative properties of
midazolam make it the most desirable benzodiazepine for use (Lera dos Santos et al.,
2013). Among the opioid drugs utilized for sedation purposes, fentanyl is the most
frequently used drug of the opioid class, but meperidine is also useful for sedation (Lera
dos Santos et al., 2013). Benzodiazepines and opioids can be administered by either a
Registered Nurse (RN) or an anesthesia provider.
A hypnotic agent, propofol, used for the induction of anesthesia, is also used for
sedation (Lera dos Santos et al., 2013). The onset of action of propofol is almost
immediate, and the half-life is short, making it ideal for rapid recovery (Lera dos Santos
et al., 2013). In addition to desirable properties for sedation, such as quicker recovery
than other regimens, both patient and physician satisfaction is high with propofol (Lera
dos Santos et al., 2013; Sipe et al., 2002). However, propofol, in many states, is limited
to administration by anesthesia providers.
2

PICO/ Project Question
For patients in the GI endoscopy suite undergoing colonoscopy, does the use of
propofol for sedation versus the use of a benzodiazepine and an opioid combination
decrease the overall cost for patients by decreasing the time until discharge from the postanesthesia care unit (PACU)? Although the combination of a benzodiazepine and an
opioid has been used for many years and is still used in GI sedation procedures today,
propofol sedation has a documented quicker induction and recovery time and may
actually improve patient movement through the GI endoscopy suite (Cohen et al., 2004).
In this project, recovery and discharge times were measured along with performance of a
cost analysis to determine which sedation regimen is more cost efficient.
Problem Statement
Colonoscopies are typically performed as outpatient procedures, meaning the
patient will be sent home from the GI endoscopy suite as soon as they meet requirements
for discharge. Quick recovery from sedation and fast turnovers are highly desirable in
settings such as these to increase patient safety and satisfaction, increase revenue, and
decrease cost. The optimal sedation regimen has a rapid onset, short duration of action,
and minimally affects cognition once sedation is terminated (Watkins et al., 2014).
Discharging patients from the recovery area with lingering sedation could cause
untoward events once the patient is out of the healthcare provider’s care; therefore,
sedation with a regimen that has quick induction and recovery times is ideal for
outpatient procedures such as colonoscopies. This not only improves patients’
satisfaction and safety, but also increases revenue and decreases cost for healthcare
organizations due to increased efficiency and avoiding accidental injuries such as falls.
3

Purpose of the Project
The purpose of this project was to determine if there was a difference in cost due
to the difference in discharge times between patients undergoing colonoscopy in the GI
endoscopy suite who are administered propofol for sedation versus those who are
administered a benzodiazepine and an opioid for sedation. Cohen and Benson (2009)
report that three colonoscopies can be performed under propofol sedation versus two
performed under midazolam and meperidine sedation in the same time frame. With that
level of efficiency, propofol seems to be the superior method of sedation for patients.
Quicker recovery time leads to shorter stays in the PACU and decreased costs.
Most comparative studies have shown that patients prefer sedation with propofol
over standard sedation drugs due to the opportunity for painless endoscopy, a very
low incidence of post-procedure side effects such as nausea and vomiting, and a
rapid return to a clearheaded state upon completion of the procedure (Cohen &
Benson, 2009, p. 566).
Needs Assessment
With colorectal cancer being the third most common type of cancer in the United
States and the third leading cause of cancer death, many people rely on screening tools
for early detection and prevention of this disease (Siegel et al., 2014; USPSTF, 2008).
“The USPSTF recommends screening for colorectal cancer using fecal occult blood
testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and
continuing until age 75 years” (USPSTF, 2008). Therefore, these procedures are
common, and many patients present to the GI endoscopy suite each day for
colonoscopies. Different sedation methods are utilized to facilitate completion of
4

colonoscopies, and significant differences may occur in patient satisfaction and
efficiency.
Although the combination of a benzodiazepine and an opiate is adequate for the
large majority of patients, there are drawbacks to the use of these drugs which
include the following: a delay of several minutes after injection before the drugs
exert their effect, lingering sedative effects that delay discharge, significant cost
because of monitoring and prolonged recovery, and morbidity and mortality as a
result of respiratory depression (Sipe et al., 2002, p. 815).
Seventy-five percent of GI procedures are completed under benzodiazepine and opioid
sedation, but survey data concludes that propofol sedation is increasing (McQuaid &
Laine, 2008). Propofol for sedation is an alternative to the common benzodiazepine and
opioid combination that has resulted in greater satisfaction and decreased recovery time
(Sipe et al., 2002). The increase in popularity of propofol sedation may be due to the fact
that providers believe that both sedation and recovery times are decreased and efficiency
of the department is improved (McQuaid & Laine, 2008). Additionally, sedation
methods have changed due to patients’ expectations of a painless procedure, desire of the
physician to improve efficiency, and reimbursement from insurance companies for
anesthesia services (Cohen & Benson, 2009). Therefore, with superior expectations from
all stakeholders, utilization of a sedation routine that is safe, time and cost efficient, and
provides the best comfort for the patient is imperative.
At the clinical site where this project was implemented, 2895 colonoscopies were
performed in 2015. Several factors such as gastroenterologist preference, comorbidities
of the patient, the patient’s current medication regimen, and patient preference determine
5

whether he or she is sedated with propofol or a benzodiazepine and opioid combination.
If propofol is found to significantly reduce discharge times and, therefore, costs, a
practice change could occur, and all sedation in the GI endoscopy suite could be
performed with propofol. Additionally, propofol sedation may improve patient
satisfaction and increase revenue for the organization.
Theoretical and Conceptual Framework
Joanne R. Duffy’s The Quality-Caring Model is the framework that was used to
guide this project. This theory was developed by Duffy in 2003 because of previous
experience with nursing care being marginalized since more modern healthcare emphasis
was placed on tasks, technology, and cost containment (Duffy, 2015). Quality once
referred to excellence of a service, but it has since expanded to include safety and value
and includes advanced practice (Duffy, 2013).
The Quality-Caring Model holds nurses accountable for developing a caring
relationship with both patients and families (Duffy, 2015). “Caring is a process that
involves the person of the nurse relating with the person of the patient” (Duffy, 2013, p.
32). In addition, a collaborative relationship with other healthcare providers is also the
responsibility of the nurse so the best interest of the patient and their family is always
upheld (Duffy, 2015). This model is an outstanding guide for this project because
advanced practice nurses must develop a caring relationship with patients and families
while developing a plan of care between providers that maintains and improves the
patient’s health by utilizing the most cost-efficient sedation regimen. By providing a
sedation technique to patients undergoing colonoscopy that enables them to recover

6

quickly while decreasing costs, both a caring and collaborative relationship has been
exhibited.
Adhering to a caring relationship with patients also means that the advanced
practice nurse provides cost-efficient care. A cost-effective analysis explores health
outcomes in relation to treatment or intervention (Butts & Rich, 2015). Advanced
practice nurses are vitally aware that economic decisions not only affect their practice,
but also the lives of their patients (Butts & Rich, 2015).
Any discussion of the situation of healthcare begins with the process of
collecting data on soaring costs, calling into question whether higher costs are
related to higher quality, and making dire predictions of the consequences of
failing to control costs (Butts & Rich, 2015, p. 320).
If patients in endoscopy suites are administered only propofol instead of benzodiazepines
and opioids, and their discharge times decrease due to enhanced recovery, costs are
decreased, profit is increased for the facility, and satisfaction remains high.
The Quality-Caring Model and cost analysis tie this project together completely
because APRNs, such as CRNAs, have the duty to provide care for patients that is both
high quality and cost efficient. Many patients deter from preventative services, such as
colonoscopies, because they simply cannot afford them. By implementing cost
containment while providing high-quality healthcare for patients, ideally more patients
will become compliant with healthcare standards, and the overall population will become
healthier. The Institute for Healthcare Improvement (IHI) developed the Triple Aim
framework that mandates healthcare must be compliant in three dimensions of (1)
improving the patient experience (i.e. quality and satisfaction), (2) improving population
7

health, and (3) reducing the cost of healthcare (IHI, 2017). Duffy’s Quality-Caring
Model and a cost-effective analysis exude the three dimensions of the Triple Aim
framework that the IHI has mandated for modern healthcare.
DNP Essentials
There are eight essential elements to the Doctor of Nursing Practice (DNP) degree
(AACN, 2006). Each of those eight essentials was met in the development of this project
and are listed as follows:
•

Essential I, Scientific Underpinnings for Practice, was met by completing a
literature review of the topic, exploring the scientific knowledge previously
discovered, and conducting an evidence-based project. “DNP prepared advanced
practice nurses bring specific expertise to their work, based on a very particular
grounding in the scholarship of application” (Zaccagnini & White, 2014, p. 4).

•

Essential II, Organizational and Systems Leadership for Quality Improvement and
Systems Thinking, was met because determination of which sedation practice
decreases cost effects the entire system of both the patient’s experience and the
anesthesia provider’s care.

•

Essential III, Clinical Scholarship and Analytical Methods for Evidence-Based
Practice, was met by conduction of a thorough literature review and a quantitative
analysis on the subject of sedation practices in the GI endoscopy suite.

•

Essential IV, Information Systems/Technology and Patient Care Technology for
the Improvement and Transformation of Health Care, was met by utilizing the
facility’s information system and collaborating with the Information Technology
(IT) personnel to retrieve data for the project. “The framework for the steps and
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skills needed for providing the best patient care in a technology-rich environment
includes the ability to use critical thinking and assessment skills to determine
what information is needed” (Zaccagnini & White, 2014, p. 141).
•

Essential V, Health Care Policy for Advocacy in Health Care, was met because
the results of this project will help the organization develop policies to improve
the delivery of healthcare by reducing costs in the GI endoscopy suite.

•

Essential VI, Inter-professional Collaboration for Improving Patient and
Population Health Outcomes, was met by collaborating with other healthcare
professionals regarding best sedation practices for the GI endoscopy suite and
determination of the best outcomes for colonoscopy patients.

•

Essential VII, Clinical Prevention and Population Health for Improving the
Nation’s Health, was met because colonoscopies are essential to reducing the
incidence and fatalities of colorectal cancer. By discovering the best sedation
practice for the colonoscopy patient, ideally, more compliance will be attained.

•

Essential VIII, Advanced Nursing Practice, was met because certified registered
nurse anesthetists (CRNAs) are key stakeholders in this project as they perform
sedation in the GI endoscopy suite and require evidence-based information on
which to base best practice.

Although advanced practice nurses are not expected to be experts in all areas of nursing,
DNP programs provide the preparation that allows their graduates to be experts in their
own field of nursing (AACN, 2006) (See Appendix A).
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CHAPTER II – REVIEW OF RELATED LITERATURE
A literature search was performed to explore the difference in discharge times of
patients sedated with propofol versus patients sedated with a benzodiazepine and an
opioid combination for colonoscopy. Several databases including CINAHL with Full
Text, Medline, PubMed, Cochrane, and Google Scholar were searched for relevant
articles. The following search terms were utilized: colonoscopy, endoscopy, sedation,
propofol, benzodiazepine, and opioid. An initial search with limitations to full text only
and publication dates between 2001 and 2016 returned 114 articles after duplications
were removed. Upon further review of all databases accessed, 12 articles were selected
because they were strongly applicable to this project. A literature matrix is included with
information from each of the included articles (See Appendix B).
Sedation Considerations for Colonoscopy
In order for patients to be comfortable during procedures such a colonoscopies,
sedation is required. Several factors such as anxiety, abdominal distention during
insufflation, and endoscope manipulation cause patients discomfort that can be avoided
with sedation (Nagelhaut & Plaus, 2014). Although some patients will tolerate the
colonoscopy using moderate sedation without difficulty, others will require deep sedation
to be comfortable. However, there are no strict boundaries in sedation as it may progress
in depth to the next level without intent from the provider (Nagelhaut & Plaus, 2014).
The provider administering sedation must be extremely vigilant in monitoring the patient
for progression and be able to rescue the patient from each depth should the need arise.
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Moderate Sedation
Moderate (conscious) sedation, which is now administered by Registered Nurses
(RNs) or Advanced Practice Registered Nurses (APRNs), was once solely administered
by anesthesia providers (Caperelli-White & Urman, 2014). The American Society of
Anesthesiologists (ASA) defines moderate sedation as
… a drug induced depression of consciousness during which patients respond
purposely to verbal commands, either alone or accompanied by light tactile
stimulation. No interventions are required to maintain a patent airway, and
spontaneous ventilation is adequate. Cardiovascular function is usually
maintained (Caperelli-White & Urman, 2014, p. 416).
Administration of moderate sedation to patients is a significant responsibility regardless
of the setting or provider. These patients need to be monitored closely because sedation
always has the potential to become deeper than the provider intended. The American
Association of Nurse Anesthetists (AANA) and the Mississippi Board of Nursing
(MSBON) declares that the RN providing conscious sedation to the patient should have
no other responsibilities than drug administration and monitoring of the patient during the
procedure (Caperelli-White & Urman, 2014; MSBON, 2009). Any other responsibilities
or tasks could easily distract the RN, or other provider, from the patient and untoward
events occur. Additionally, some institutions and boards of nursing require that
professionals administering moderate sedation have additional education and training in
the clinical and administrative aspects of sedation (Caperelli-White & Urman, 2014;
MSBON, 2009).
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Deep Sedation
Progression from moderate sedation to deep sedation causes different physiologic
responses to occur. Instead of immediately responding to verbal or tactile stimulation,
the patient may require repeated or even painful stimulation to become arousable
(AANA, 2016; Obara et al., 2015). In deep sedation, spontaneous ventilation may be
inadequate, and intervention may be required to maintain a patent airway; however,
cardiovascular function is typically maintained (AANA, 2016; Obara et al., 2015).
Rescue from deep sedation requires providers proficient in airway management because
respiratory depression and airway obstruction hold a high incidence in patient death for
those undergoing sedation for endoscopy (Obara et al., 2015). Furthermore, the
incidence of airway emergencies (i.e. airway obstruction, respiratory depression) is twice
as high outside the operating room in remote locations, such as GI endoscopy suites
(Obara et al., 2015).
Monitored Anesthesia Care
Monitored anesthesia care (MAC) is an anesthetic technique in which an
anesthesia provider conducts a preoperative assessment, develops a plan for sedation,
administers care during the procedure, and manages the patient postoperatively (ASA,
2013; Miller & Pardo, 2011). “An ideal anesthetic technique would incorporate optimal
patient safety and satisfaction, provide excellent operating conditions for the surgeon,
allow rapid recovery, and avoid postoperative side effects” (Miller & Pardo, 2011, p.
191). The ASA states that MAC includes varying levels of sedation, analgesia, and
anxiolysis, therefore, this technique is limited to anesthesia providers so that conversion
to a general anesthetic and airway management is feasible should the need arise (ASA,
12

2013; Das & Ghosh, 2015). Drugs ideal for sedation should have a rapid onset and
clearance, be easy to titrate, and have minimal side effects, especially lacking
cardiovascular and respiratory depression (Das & Ghosh, 2015). Propofol produces a
more rapid, clear-headed recovery and protects against postoperative nausea and
vomiting (PONV) than does midazolam and opioid combinations, making it an ideal drug
for sedation (Das & Ghosh, 2015). Even though midazolam has a short elimination halflife, it causes prolonged psychomotor impairment and when used with an opioid, severe
cardiovascular and respiratory depression can be seen (Das & Ghosh, 2015).
Mississippi’s Position Statement on Sedation
Each state has its own position statement regarding the administration and
monitoring of patients under each level of sedation. Mississippi’s position statement
reads that even though optimal anesthesia care is best provided by anesthesiologists and
CRNAs, the high clinical demand for intravenous (IV) sedation permits non-CRNA RNs
to administer moderate sedation (MSBON, 2009). RNs are not allowed by the
Mississippi State Board of Nursing to administer deep sedation, general anesthesia, or
any pharmacologic agents that are used in the administration of general anesthesia
(MSBON, 2009). For the RNs providing moderate sedation to patients, the Mississippi
State Board of Nursing deems it necessary for those providers to obtain additional
education from their facilities in the administration, monitoring, and management of
sedated patients (MSBON, 2009). In addition, the anesthesia provider, attending
physician, or CRNA who ordered the sedation for the patient must be physically present
and immediately available should an emergency arise (MSBON, 2009).
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Propofol
Propofol, a sedative-hypnotic, is one of the newest anesthetic induction drugs,
first introduced into clinical practice in 1989, and has since become the drug of choice for
many anesthesia aspects (Ouellette & Joyce, 2011). The mechanism of action of
propofol is exerted primarily by effect on gamma-aminobutyric acid (GABA) receptors
(Ouellette & Joyce, 2011). GABA is the primary inhibitory neurotransmitter of the
central nervous system (CNS), and activation of GABA receptors by propofol causes an
increase of chloride transmembrane conduction causing a hyperpolarization of the cell to
occur and inhibition of the neuron (Ouellette & Joyce, 2011). One of the more desirable
effects of propofol that makes it different from other anesthesia drugs is a rapid and
complete reawakening that occurs because propofol redistributes away from the effect
site (brain) to other tissues that are not as well perfused (muscles) (Ouellette & Joyce,
2011). Additionally, the metabolic clearance of propofol exceeds hepatic blood flow,
which suggests an extra-hepatic metabolic pathway; pulmonary uptake and elimination of
propofol is possibly an extra-hepatic metabolic pathway (Ouellette & Joyce, 2011).
Although propofol is metabolized extensively and rapidly by the hepatic system, and
renal elimination is dominant, there is no evidence that neither hepatic nor renal
dysfunction impacts the rapid redistribution and quick reawakening associated with
propofol (Ouellette & Joyce, 2011). Another desirable effect of propofol, regardless of
the anesthetic technique, is its anti-emetic properties that decrease the occurrence of
PONV (Ouellette & Joyce, 2011).
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Fentanyl
Fentanyl is an opioid that provides analgesia by stimulating 𝜇 receptors (Ouellette
& Joyce, 2011). The rapid onset and short duration of action make fentanyl an ideal drug
for use in anesthesia (Ouellette & Joyce, 2011). Pharmacokinetics associated with
fentanyl are distribution time 1.7 minutes, redistribution time 13 minutes, and half-life
219 minutes (Ouellette & Joyce, 2011). The onset of action of fentanyl is almost
immediate, and the duration of effects typically lasts 30 minutes to one hour (Ouellette &
Joyce, 2011). Fentanyl is metabolized in the liver by the cytochrome P 450 (CYP)
system, and up to 75% is eliminated in the urine as the original drug (Ouellette & Joyce,
2011).
Meperidine
Meperidine is a synthetic opioid that is used in moderate sedation. Meperidine is
a derivative of the phenylpiperidine group with a half-life of 2.5 to 4 hours that is
significantly increased by renal failure (Miller & Pardo, 2011). The metabolite of
meperidine, normeperidine, also produces analgesia, central nervous system (CNS)
excitability, and seizures (Miller & Pardo, 2011; Ouellette & Joyce, 2011). Additionally,
the chemical structure of meperidine is similar to atropine, which causes increased heart
rate (Butterworth, Mackey, & Wasnick, 2013). Meperidine should not be used in patients
with renal failure or CNS disturbances (Ouellette & Joyce, 2011).
Midazolam
Midazolam is a benzodiazepine drug that produces anterograde amnesia from the
time of injection and typically lasts through the recovery period (Ouellette & Joyce,
2011). It produces strong sedative effects and quick recovery, making it the most
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commonly used benzodiazepine for sedation (Ouellette & Joyce, 2011). The effects of
midazolam are exerted by binding to GABAa receptors, opening the chloride channels for
extensive periods, hyperpolarizing the cells, and making the cell less excitable (Ouellette
& Joyce, 2011). Of the benzodiazepine drugs in clinical use, midazolam is the best
choice because of its higher clearance level (6-8 ml/kg/min) (diazepam or lorazepam0.2-1 ml/kg/min) (Ouellette & Joyce, 2011). Metabolism of midazolam occurs in the
hepatic system due to the CYP 450 system, and it is eliminated by the renal system
(Ouellette & Joyce, 2011). The active metabolites of midazolam are quickly conjugated
so that no secondary effects of the drug are exhibited; whereas, the effects of diazepam
can be seen up to 20 hours after administration (Ouellette & Joyce, 2011). However,
midazolam does cause greater respiratory depression than other benzodiazepines
(Ouellette & Joyce, 2011).
Comparison of Sedation Regimens
In the past, researchers have studied the difference in recovery and discharge
times of patients who were sedated for procedures in the GI endoscopy suite and found
that propofol is superior to a benzodiazepine and opioid combination for sedation because
it allows improved sedation, faster recoveries, and higher efficiency of department
function (Poulos, Kalogerinis, & Caudle, 2013). Poulos et al. (2013) performed a
retrospective cohort trial that studied 951 patients undergoing colonoscopy or
esophagogastroduodenoscopy (EGD) from 2007 to 2010 that were sedated either with (1)
propofol, (2) midazolam, fentanyl, and propofol, or (3) midazolam and fentanyl. After
the study was completed, findings indicated that sedation with propofol resulted in
quicker inductions, shorter procedures, and faster recoveries than patients who were
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sedated with (1) midazolam, fentanyl, and propofol or (2) midazolam and fentanyl
(Poulos et al., 2013).
Sipe et al. (2002) published a randomized, blinded, prospective study of 80
patients undergoing colonoscopy under sedation either with (1) propofol or (2)
midazolam and meperidine. The mean times until sedation, recovery, and discharge were
quicker by an average of 34 minutes in the propofol group (Sipe et al., 2002). In addition
to providing more time efficient sedation and recovery, both patient and nurse
satisfaction was greater among the propofol group. Nurses involved in this study
reported that the level of sedation was adequate in 100% of propofol patients, whereas it
was only adequate in 90% of the midazolam and meperidine patients (Sipe et al., 2002).
When surveyed, 100% of patients in the propofol group were satisfied with their
sedation, whereas five patients from the midazolam and meperidine group reported that
their sedation could have been adjusted, either more or less (Sipe et al., 2002).
Synthesis of the Literature
From the literature reviewed for this project, all authors concluded that propofol
was superior to other methods of sedation for quicker recovery and discharge times from
the PACU. The decrease in time required for recovery may assist to decrease overall
costs for patients and increase revenue for organizations, however, other factors such as
anesthesia provider cost for administration of propofol versus RN administration of a
benzodiazepine and an opioid must be considered. Both methods of sedation are safe and
effective; however, patient satisfaction tends to be higher with propofol. Different
organizations must conduct their own cost-benefit analysis to determine if the time saved
is beneficial even with the cost of anesthesia provider administration of propofol.
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CHAPTER III - METHODOLOGY
Target Outcomes
The target outcome of this study was to determine if decreased costs are seen in
patients who are administered propofol for sedation rather than a benzodiazepine and
opioid combination to facilitate colonoscopy in the GI endoscopy suite. Previous studies
have indicated that using propofol for sedation quickens recovery of patients and prepares
them for discharge sooner (Poulos et al., 2013; Sipe et al, 2002; Vargo et al., 2002). The
outcome was determined by comparing the difference in discharge times, cost for
provider administration of sedation (anesthesia provider or RN), and cost of drugs that
are administered for sedation between patients who are sedated with propofol and those
sedated with midazolam and fentanyl/meperidine in a GI endoscopy suite (See Appendix
C and D, Logic Model and SWOT Analysis).
Setting
The clinical setting for this project was a GI endoscopy suite at a 215-bed acute
care facility in rural Mississippi. This was an optimal setting to study the difference in
discharge times between patients sedated with propofol versus the patients sedated with a
benzodiazepine and opioid combination because, on a daily basis, many patients are seen
in this particular GI endoscopy suite and are sedated with propofol or a benzodiazepine
and opioid combination. At this clinical site, both EGDs and colonoscopies are
performed daily, but for this project, only colonoscopies were studied.
Population and Sample
This project utilized a retrospective chart review of patients ASA physical status
(PS) I or II and ages 18 to 55 (See Appendix E, ASA PS Classification). Based on a G18

Power Analysis, for a moderate effect size, a total of 176 charts were needed with 88 in
each group (Buchner, Erdfelder, Faul, & Lang, 2007). These charts were selected from
cases January 1, 2015, through December 31, 2015, in the GI endoscopy suite at the acute
care facility mentioned above. Exclusion criteria included the following: ASA-PS III or
IV, non-English speaking, pregnancy, allergy to eggs, fentanyl, or midazolam, previous
neurological deficit, patients scheduled for colonoscopy and EGD in the same day,
hospital inpatients undergoing colonoscopy, and patients undergoing emergency
procedures. Sampling for this project was achieved by a convenience sample
retrospective chart review of previous colonoscopies where all patient criteria had been
met.
Barriers
A potential barrier to this project was disinterest of the gastroenterologists and GI
endoscopy suite staff where this project took place. Without the interest and support of
the providers who administer the daily bedside care, gaining approval for this project
from administration would not have been possible. Educating the physicians and staff
that the results of this project could help to improve efficiency and thereby reduce costs
in the future were explained to help gain their interest. The goal of this project was to
determine which sedation regimen is most cost-effective and provides quicker discharge
times for patients as well as the potential for increased throughput in the department.
Statistical Analysis
For patients in the GI endoscopy suite undergoing colonoscopy, does the use of
propofol for sedation versus the use of a benzodiazepine and an opioid combination
decrease the overall cost for patients by decreasing the time until discharge from the post19

anesthesia care unit (PACU)? The null hypothesis was that there were no significant
differences between the two groups on discharge times after completion of the
colonoscopy. The hypothesis was that the propofol group would be discharged
significantly quicker than the benzodiazepine and opioid combination group.
Significance was set apriori at less than or equal to 0.05. For this study, a one-tailed
independent t-test was used to determine statistical significance. An independent t-test is
used for statistical analysis when two different groups (people, things, etc.) are being
compared on the same dependent variable (Frey, 2016). A one-tailed t-test was used
because of the directionality of the hypothesis. In this project, two different groups of
patients were studied, and the particular interest was the difference in mean discharge
times from PACU after sedation for colonoscopy. A chi-square test was performed to
examine whether demographic data differences from each group may explain t-test
results. Chi-square tests compare the occurrences in each category to the hypothesized
outcome (Frey, 2016).
Collection of Data
In this project, the independent variable was the method of sedation, both
propofol and benzodiazepine and opioid combination. The dependent variable was the
discharge time from PACU, with the resulting cost associated with provider cost for
administration of sedation, and cost of drugs used for sedation. Data collected were ASA
PS, age, gender, type of sedation, time of sedation start and end, time of procedure start
and end, time until discharge from PACU in minutes, cost of provider administration of
sedation, and cost of each drug used for sedation. The time of procedure end to discharge
from the PACU in minutes was the time that was analyzed. Once data were collected and
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the statistical analysis was performed, results were presented to anesthesia providers in
the facility where the project was conducted. An informal interview was conducted with
anesthesia providers to gain their insight on results of this project and how to ensure the
GI endoscopy suite can become both time and cost efficient.
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CHAPTER IV – RESULTS
Analysis of Data
For this DNP project, 3595 charts were reviewed and 176 were included in this
study per recommendation of the G power analysis previously performed by the
researcher. The 176 charts were chosen by a convenience sample on a first come, first
serve basis beginning with records from January 2015, until 88 charts meeting the
inclusion criteria were in each group. Patients included in this project were ASA PS I or
II with a minimum age of 18 years, a maximum age of 55 years, and a mean age of 45.9
years. There were 115 females and 61 males who met inclusion criteria. Of the 176 total
patients included, 161 were ASA PS II and 15 were ASA PS I.
Table 1
Demographical Data
Propofol group

Benzodiazepine and
opioid group

Total

32
56

29
59

61 (34.7%)
115 (65.3%)

4
84

11
77

15 (8.5%)
161 (91.5%)

18
55
44.4

20
55
47.3

Gender
Male
Female
ASA
ASA PS I
ASA PS II
Age (in years)
Minimum
Maximum
Mean

A one-tailed independent sample t-test was utilized to determine differences
between the two different methods of sedation since the researcher hypothesized that
sedation with propofol would render faster discharge times from PACU. There were no
significant outliers or missing data, and all data were both valid and reliable (i.e. no
22

incorrect data were transposed into statistical analysis). A statistically significant
difference was found between the discharge times in minutes of the two different groups
of patients (group propofol M= 80.99, SD= 15.36 and group benzodiazepine and opioid
M= 84.58, SD= 13.42) (p= 0.05). The results of this analysis accept the hypothesis that
propofol sedation for patients undergoing colonoscopy in the GI endoscopy suite renders
quicker discharge times than does sedation with a benzodiazepine and an opioid.
Table 2
Mean Sedation, Procedure, and PACU Times

Sedation time
Procedure time
PACU time

Propofol
23.53 minutes
16.93 minutes
75.5 minutes

Benzodiazepine and opioid
9.16 minutes
23.59 minutes
81.26 minutes

A chi-square (2) test was performed on the demographical data of patients
included in this project to ensure that differences in demographics did not affect results of
the analysis. The demographical data included in the chi-square test were age, gender
(male and female), and ASA PS (I and II) classification. Results of this test confirmed
the null hypothesis that no statistically significant differences in demographical data were
present that may have affected the difference in discharge times between the two sedation
groups (2(4)= 3.87, p< 0.05).
Cost Analysis
A cost analysis was performed on variables of this DNP project including the cost
of PACU time in minutes, cost of administration of sedation by anesthesia providers
versus RNs, and cost of common drugs used for sedation. The costs included in Table 3
and Table 4 are the major costs but are only part of what is billed to patients after having
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a colonoscopy. Additionally, CRNA salaries are higher than salaries of RNs, which can
be a major cost to the facility. The visual cost analysis confirmed that administration of
propofol by anesthesia providers is more costly ($640.38) than moderate sedation with a
benzodiazepine and an opioid administered by a RN (414.77 to $415.77).
Upon further investigation of reimbursement for colonoscopies, the mean
collected monies at the facility where this project was performed are $939.92 regardless
of which type of sedation was provided. Even though the total dollar amount billed to the
patient is more for anesthesia provided sedation with propofol ($640.38), the same
amount is collected on colonoscopies with either type of sedation. Therefore, since
propofol is more time efficient, there is potential that increased throughput of patients and
overall increased number of patients able to be seen could result in increased revenue for
the facility.
Table 3
MAC cost—provided by anesthesia providers
Variable
MAC
Propofol 10mg/ml
(50ml)
PACU

Cost per unit
Meantime/dose
$250.00 flat fee then 9.16 minutes
$50.00/15 minutes
$76.35
210mg

Total mean cost
$280.53

$283.50
(indefinitely)

$283.50

---

$76.35

Total Cost
$640.38
Average reimbursement for colonoscopies for both types of sedation is $939.92
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Table 4
Moderate sedation cost—provided by RNs
Variable
Moderate Sedation
Midazolam 2mg/2ml
(2ml)
Meperidine 50mg/ml
(1ml)
Fentanyl 50mcg/ml
(2ml)
PACU
Total Cost

Cost per unit
$20.00/ 15 minutes
$16.65

Meantime/dose
23.53 minutes
7.01mg

Total mean cost
$31.37
$66.60

$17.15

69.55mg

$34.30

$16.65

130mcg

$33.30

$283.50 (indefinitely)

---

$283.50
$414.77 or
$415.77
Average reimbursement for colonoscopies for both types of sedation is $939.92
For moderate sedation either midazolam and meperidine or midazolam and fentanyl are given together.

Presentation of Results to Anesthesia Providers
After the statistical and cost analyses, results were informally presented to
anesthesia providers in the facility where this project was performed. Anecdotal
feedback provided valuable insight into how project findings were processed by the
anesthesia providers. Anesthesia providers agreed that while MAC with propofol is
necessary for certain patients, it may not be the most cost effective method of sedation in
the GI endoscopy suite. Anesthesia provided sedation costs the facility more than does
moderate sedation by RNs (CRNA salary versus RN salary). However, if propofol
sedation is going to be delivered, patients should be discharged from PACU when
discharge criteria are met so patient throughput is increased. Anesthesia providers agreed
that if discharge time for propofol sedation was decreased, by adhering to protocols in
place, more patients could be seen, and more revenue could be captured, particularly
since reimbursement is the same for both methods of sedation.
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Conclusion
The purpose of this DNP project was to determine which sedation regimen was
both more time and cost efficient for patients undergoing colonoscopy in the GI
endoscopy suite. Results of analyses were found to conclude that while propofol sedation
was more time efficient, sedation with a benzodiazepine and opioid was more cost
efficient. Although the literature suggested that propofol sedation is more time and cost
efficient, there were limitations specific to the clinical site that may have influenced the
results of this DNP project. These are presented in the Discussion.
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CHAPTER V – DISCUSSION
Limitations
Limitations were present while conducting this project. One limiting factor was
that the project was a retrospective chart review that utilized convenience samples of
data. Charting errors, illegible handwriting of providers, and coding errors potentially
resulted in data reliability issues. Other limiting factors of this project are clinical sitespecific procedures. In the acute care facility where this project was conducted, most
patients undergoing sedation for GI procedures were kept in PACU for 60 minutes or
greater regardless of when discharge criteria were met. Additionally, the
gastroenterologist who performed the procedure made rounds on each patient after his or
her endoscopy procedure before he or she was allowed to be discharged. After
discussion with PACU RNs at this facility, the procedure to keep patients for 60 minutes
has changed since this project. Currently, PACU RNs are attempting to discharge
patients sedated with propofol within 30 minutes if all discharge criteria are met and he
or she has been seen by the gastroenterologist. Moderate sedation patients are still kept
in PACU 60 minutes before discharge.
Benefits
Retrospective chart reviews are beneficial because all medical records are readily
accessible and data is easily collected. Challenges of performing a prospective project
are eliminated with gathering of data from previous cases. No additional costs, resources,
time, or procedures were required of the staff in the GI endoscopy suite for facilitation of
this project.
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Theoretical Model Applied to This Project
The two frameworks that were used to guide this project were Duffy’s QualityCaring Model and cost efficiency. While providing high-quality care is first and
foremost when caring for patients, APRNs, such as CRNAs, have to duty to also provide
cost efficient care. Safety and value are now included in quality care (Duffy, 2015). In
this project, both time and cost efficiency were compared for two different methods of
sedation. While one method was found to be more time efficient, and the other method
was found to be more cost efficient, the provider must determine which method is most
suitable for the patient. Quality care and cost efficiency can be delivered together in most
cases. However, there are times that the best plan for the patient is not the least
expensive, and times when the most expensive is not the best plan. Each patient has to be
evaluated for who he or she is and what he or she needs. Duffy’s Quality-Caring Model
epitomizes providing individualized care that is of highest quality for each patient.
However, cost does affect patients, and performance of a cost-effective analysis allows
the CRNA to deliver quality healthcare that is cost effective so that patients can afford to
receive care that will facilitate his or her treatment or intervention. Delivery of highquality, low-cost healthcare is a skill that is made possible with evidence-based practice.
Implications for Future Practice
Future projects should be conducted in this setting to determine if the change in
PACU time before discharge, by following new unit protocols significantly impacted and
decreased the mean propofol discharge time of 80.99 minutes. Cost of facility operations
such as staffing costs (PACU RNs) and throughput of patients, 2.7 versus 1, may be
significant enough for the facility to consider utilizing anesthesia providers for MAC for
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all patients undergoing colonoscopies in the GI endoscopy suite. Decreased time until
discharge with propofol could increase the overall number of patients in one day and
increase the revenue gained for the facility. Additionally, examining patient satisfaction
between the two sedation methods could be considered. Patient satisfaction drives
reimbursement of healthcare facilities today, and increased satisfaction equals increased
reimbursement (Berkowitz, 2016).
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APPENDIX A – DNP Essentials
Table A1.
DNP Essentials
Essential I

Essential II

Essential III

Essential IV

Essential V

Essential VI

Essential VII

Scientific Underpinnings for
Practice

Conduction of a
literature review,
exploration of previous
scientific knowledge,
and conducting
evidence-based study
Organizational and Systems
Determination of which
Leadership for Quality
sedation decreases
Improvement and Systems
costs effects the entire
Thinking
systems of both the
patient’s experience
and the anesthesia
provider’s care
Clinical Scholarship and
Conduction of a
Analytical Methods for
literature review and a
Evidence-Based Practice
quantitative analysis
Information
Utilization of the
Systems/Technology and Patient facility’s information
Care Technology
system and cooperation
with the IT department
for retrieval of
information
Health Care Policy for Advocacy The results of this
in Health Care
project will guide new
policies in the GI
endoscopy suite
Interprofessional Collaboration
Collaboration with
for Improving Patient and
other healthcare
Population Health Outcomes
professionals for the
best sedation regimen
to decrease cost and
discharge times for
colonoscopy patients in
the GI endoscopy suite
Clinical Prevention and
Determination of which
Population Health for Improving sedation practice
the Nation’s Health
decreases costs and
enhances recovery to
gain compliance of
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Essential VIII

Advanced Nursing Practice

(AACN, 2006; Zaccagnini & White, 2014)
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patients that meet
requirements for
screening
colonoscopies
CRNAs are APRNs
that deliver sedation to
patients undergoing
colonoscopy in the GI
endoscopy suite

APPENDIX B – Literature Matrix
Author/Year/Title

Level/Grade Design

Caperelli-White, L.
Level 4/Grade
and Urman, R. D.
D
(2014). “Developing a
moderate sedation
policy: essential
elements and
evidence-based
considerations.”

Expert opinion/
Commentary

Sample/Data Findings
Collection

Limitations

Recommendations

N/A

N/A

Each facility must
establish their own
policies and
procedures regarding
sedation practice that
aligns with evidencebased practice and
abides by practice
laws for the
disciplines.
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Policies and
procedures
should guide
how and by
whom sedation
is performed.
Policies should
follow practice
laws when
determining
which
medications can
be administered
by whom and
the type of
monitoring
equipment
utilized. Preprocedure
assessments
must be
performed as
well as postprocedure
recovery plans
implemented.

Author/Year/Title

Level/Grade Design

Sample/Data Findings
Collection

Limitations

Recommendations

Cohen, L. B., and
Benson, A. A.
(2009). “Issues in
Endoscopic
Sedation.”

Level 4/Grade
D

N/A

N/A

More outcome
studies need to be
performed with
endoscopist-directed
sedation using
propofol.

Expert
opinion/Commentary
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MAC
decreases
time in the
procedure for
patients and
increases
their
satisfaction
with the
procedure.
Also, new
drugs such as
fospropofol
and new
methods such
as computer
assisted and
patient
controlled
sedation are
options for
sedation
methods in
the GI lab.
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Author/Year/Title

Level/Grade Design

Sample/Data Findings
Collection

Limitations

Recommendations

Cohen, L. B., Hightower,
C. D., Wood, D. A.,
Miller, K. M., and
Aisenberg, J. (2004).
“Moderate level sedation
during endoscopy: a
prospective study using
low-dose propofol,
meperidine/fentanyl, and
midazolam.”

Level 2+/
Grade C

100 consecutive
patients, who
met inclusion
criteria, that
presented either
for EGD or
colonoscopy
and were
sedated with
propofol,
midazolam, and
fentanyl (or
meperidine)
were studied at
intervals to
determine the
depth of
sedation (mild,
moderate, deep)
that occurred
during the
procedure and if
propofol could
be administered
without entering
deep sedation.

This study only
looked at one
group of patients
and did not have
a comparison
group. The
study was
limited to
determine
whether the
addition of
propofol to the
sedation regimen
of midazolam
and a narcotic
would actually
decrease
recovery time
while allowing
moderate
sedation to
ensue.

The researchers feel
that the addition of
propofol to midazolam
and an opioid for
sedation improves
recovery and turnover
times without the
patient experiencing
deep sedation.
However, they
recognize that
randomized, controlled
trials need to be
performed before
making conclusions.

Cohort study

Of the 100 patients
studied, 76
colonoscopies and
26 EGDs, the
surveyor found that
77% of patients
were minimally
sedated, 21% were
moderately sedated,
and only 2%
entered deep
sedation. They
concluded that
sedation with lowdose propofol, a
narcotic, and
midazolam
produces moderate
sedation.

Author/Year/Titl
e

Level/Grad
e

Design

Das, S. and Ghosh,
S. (2015).
“Monitored
anesthesia care: An
overview.”

Level 4/Grade Expert
D
Opinion/Commentar
y
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Sample/Dat
a Collection

Findings

Limitation
s

Recommendation
s

N/A

MAC is an
anesthesia
technique that
leaves the patient
spontaneously
breathing and
preserves airway
reflexes while
offering sedation
and analgesia for
procedures. This
articles also
provides
information on
propofol and
dexmetatomidine
, two popular
drugs that are
administered
during MAC.

N/A

The author
recommended that
clinicians discern
which patients are
right for MAC and
which are not. Also,
research on different
techniques for
pediatric and
geriatric populations
needs to performed
to offer a
recommendation for
those populations.
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Author/Year/Title

Level/Grade Design

Sample/Data Findings
Collection

Limitations

Recommendations

Lera dos Santos, M. E.,
Maluf-Filho, F., Chaves,
D. M., Matuguma, S. E.,
Ide, E., Luz, G. de
O., de Souza, T.
F., Pessorrusso, F. C. M.,
de Moura, E. G. H., and
Sakai, P. (2013). “Deep
sedation during
gastrointestinal
endoscopy: Propofolfentanyl and midazolamfentanyl regimens.”

Level 1+/Grade
A

200 patients
were recruited
and were
randomly
placed into 2
groups. Those
2 groups were
sedation with
either propofol
and fentanyl or
midazolam and
fentanyl.

This study
included only
patients who
fall into the
ASA I or II
class. Those
patients are
relatively
healthy. This
limits the
validity of the
study when
discussing
patients with
comorbidities
that make
them ASA III
or greater.

The
recommendations
of the authors of
this study is that
patients ASA I or
II can be safely
administered
propofol and
fentanyl for
conscious sedation
for upper
endoscopy. They
also state that the
presence of an
anesthesiologist is
not mandatory for
the administration
of this drug.

Prospective,
single-blind,
randomized
controlled trial.

In the propofol
and fentanyl
group, times to
induction of
sedation,
recovery, and
discharge were
shorter than the
midazolam and
fentanyl group.
Deep sedation
occurred in 25%
of propofol and
fentanyl group
and 11% of
midazolam and
fentanyl group
according to
OAA/S scale.
According to the
BIS monitor,
11% of patients
in the propofol
and fentanyl
group were
deeply sedation
compared to 7%
of the midazolam
and fentanyl
group.

Author/Year/Title

Level/Grade Design
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Mandel, J. E., Tanner,
Level 1++/
J. W., Lichtenstein, G. Grade A
R., Metz, D. C.,
Katzka, D. A.,
Ginsberg, G. G.,
Kochman, M. L.
(2008). “A
randomized, controlled,
double-blind trial of
patient-controlled
sedation with
propofol/remifentanil
versus
midazolam/fentanyl for
colonoscopy.”

Randomized,
controlled,
double-blind
trial.

Sample/Data Findings
Collection

Limitations

Recommendations

Fifty patients
undergoing
colonoscopy
were
randomized to
either
midazolam
and fentanyl
group or
propofol and
remifentanil
group
administered
by patientcontrolled
sedation.

Fixed ratios of
narcotics and
sedatives were
used in this
study, which
allowed single
syringe use.
However, this
does not allow
for tailoring
drug doses to
patients.

The authors state that
when applied to
other procedures, the
efficacy of this form
of sedation is not
known. However,
forming an efficient
sedation protocol
could increase
throughput of
patients and decrease
costs.

Induction of
sedation and
recovery was
significantly
shorter in the
propofol and
remifentanil
group than in
the midazolam
and fentanyl
group.
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Author/Year/Title

Level/Grade Design

Sample/Data Findings
Collection

Limitations

Recommendations

McQuaid, K. R., and
Laine, L. (2008). “A
systematic review and
meta-analysis of
randomized,
controlled trials of
moderate sedation for
routine endoscopic
procedures.”

Level 1-/
Grade A

36 studies, all
randomized
controlled
trials, were
reviewed in
this study.
Databases
EMBASE
(1980January 2007)
and
MEDLINE
(1950 to
January 2007)
were searched
for the RCTs.

Design,
regimen, and
outcome
variability and
poor
methodologic
quality (Jadad
score <3 in
23/36 trials.

Controlled trials
recommended to
study lower doses of
propofol plus
narcotics and
benzodiazepines
versus propofol
alone or
benzodiazepines and
narcotics.

Systematic
review of
randomized
controlled trials

36 studies were
included in this
systematic review,
and many forms
of sedation were
reviewed.
Sedation and
recovery times
were shorter with
propofol sedation
versus sedation
with narcotics,
benzodiazepines,
combination of
narcotics and
benzodiazepines,
or combination of
narcotics and
propofol.

Author/Year/Title

Level/Grade Design

Obara, K., Haruma, K., Level 4/
Irisawa, A., Kaise, M., Grade D
Gotoda, T., Sugiyama,
M., Tanabe, S.,
Horiuchi, A., Fujita,
N., Ozaki, M.,
Yoshida, M., Matsui,
T., Ichinose, M., and
Kaminishi, M. (2015).
“Guidelines for
sedation in
gastroenterological
endoscopy.”

Guideline/
Expert opinion/
Commentary
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Sample/Data Findings
Collection

Limitations

Recommendations

N/A

Several authors
of this study
received
royalty, lecture
fees,
scholarships,
and study
group
sponsorships
from various
pharmaceutical
companies;
however, no
funding was
received for
this study.

The authors agree
that change occurs
rapidly in the
medical field, so
guidelines should be
reviewed and
changed accordingly
every few years.

Initial
guidelines for
endoscopy
sedation were
created in Japan
in 1999, updated
in 2006, and
updated again in
2010. They
review the
pharmacology
of different
drugs used for
sedation for
endoscopic
procedures.
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Author/Year/Title

Level/Grade Design

Sample/Data Findings
Collection

Limitations

Recommendations

Poulos, J. E.,
Kalogerinis, P. T., and
Caudle, J. N. (2013).
“Propofol compared
with combination
propofol or
midazolam/fentanyl for
endoscopy in a
community setting.”

Level 2+/
Grade C

Data from 951
patients at an
outpatient
endoscopy
center from
2007 to 2010
were studied.
Those patients
were
undergoing
colonoscopy
or EGD at the
time.

Nonrandomized,
non-blinded
study that
utilized a
retrospective
chart review

This study
recommends that
various states follow
their board of
nursing regulations
in administration of
propofol before
making any practice
changes. Many
BONs do not allow
propofol to be
administered by
anyone not trained in
rescue from deep
sedation.

Retrospective
Cohort Study

Propofol
sedation
generated less
time in the
endoscopy unit,
faster recovery,
and faster
discharge than
did propofol,
midazolam, and
fentanyl, or
midazolam and
fentanyl.
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Author/Year/Title

Level/Grade Design

Sample/Data Findings
Collection

Limitations

Recommendations

Sipe, B. W., Rex, D.
K., Latinovich, D.,
Overley, C., Kinser, K.,
Bratcher, L., and
Kareke, D. (2002).
“Propofol versus
midazolam/meperidine
for outpatient
colonoscopy:
administration by
nurses supervised by
endoscopists.”

Level
1+/Grade A

80 ASA class
I or II
outpatients
undergoing
colonoscopy
were
randomized to
receive either
propofol or
midazolam
and
meperidine for
sedation. All
drugs were
administered
by nurses and
supervised by
the
endoscopist

Single center
study.
Sedation,
including
propofol,
performed by
registered
nurses
supervised by
endoscopists.
Propofol
typically
administered
by anesthesia
providers.
Only ASA I
or II patients
included.

This study
recommends that
propofol be used
for sedation for
colonoscopies
because patients
typically
experience less
pain than with
other sedation
methods.

Randomized,
blinded trial

Patients sedated
with propofol
for
colonoscopies
had faster
sedation times,
deeper sedation,
quicker
recoveries, and
were discharged
sooner than
patients sedated
with midazolam
and meperidine.
4 patients in the
midazolam and
meperidine
group
developed
minor
complications
(hypotension,
bradycardia,
tachycardia) and
1 patient in the
propofol group
desaturated
during an
episode of
epistaxis.
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Author/Year/Title

Level/Grade Design

Sample/Data Findings
Collection

Limitations

Recommendations

Vargo, J. J., Zuccaro
Jr., G., Dumot, J. A.,
Shermock, K. M.,
Morrow, J. B.,
Conwell, D. L., Trolli,
P. A., and Maurer, W.
G. (2002).
“Gastroenterologistsadministered propofol
versus meperidine and
midazolam for
advanced upper
endoscopy: A
prospective,
randomized trial.”

Level 1+/
Grade A

75 patients
presenting for
ERCP and
EUS were
randomly
selected for
sedation by
propofol or
midazolam
and
meperidine.
All patients
were similar in
age, sex, BMI,
ASA physical
status,
education, and
sedation
history.

Patients
included in this
study were
ASA I or II
and generally
healthy.
Patients ASA
III or higher
have more
comorbidities
and respond to
medications
differently.
Also, in this
study, propofol
was
administered
by bolus
injections
instead of
infusion which
may cause
variability in
the plasma
levels of the
drug and
sedation.

The authors of this
study recommend
further studies of
nurse-administered
propofol to
decrease the cost of
propofol sedation
for patients.
However, the
policies of propofol
administration
must be reviewed
carefully.

Prospective,
single-blind,
randomized
controlled trial.

Patients in the
propofol
sedation group
had shorter
recovery times
and were
quicker to
recover to
baseline activity
and dietary level
24 hours postprocedure.
However, the
cost to
administer
propofol was
higher than the
administration
of meperidine
and midazolam.
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Author/Year/Title

Level/Grade Design

Sample/Data Findings
Collection

Limitations

Recommendations

Watkins, T. J., Bonds,
R. L., Hodges, K.,
Goettle, B. B., Dobson,
D. A. M., and Maye, J.
P. (2014). “Evaluation
of postprocedure
cognitive function
using 3 distinct
standard sedation
regimens for
endoscopic
procedures.”

Level
1+/Grade A

96 patients,
both male, and
female were
included in
this study.
The sample
was a
convenience
sample of
patients
presenting for
colonoscopy
at a medical
center in
Maryland.

Only ASA I
and II patients
included,
patients, were
presented with
questionnaires
both before and
after their
procedure
which could
have
familiarized
them with the
questions and
answers, and
the need to
follow up with
patients at both
24 and 48
hours postprocedure.

The authors of this
study recommend
that propofol alone
may be optimal for
endoscopy
procedures when
attempting to
decrease POCD

Prospective,
single-blind,
randomized trial

This authors of
this study
concluded that
propofol
sedation has the
least impact on
postoperative
cognitive
dysfunction at
both 24 and 48
hours postprocedure than
the other
methods of
sedation
studied,
propofol plus
fentanyl or
midazolam plus
fentanyl.

APPENDIX C – Logic Model
Input
IT assistance to
access
colonoscopy charts
in GI endoscopy
suite from 2015
IRB approval
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Cost information
of medications
used for sedation
Cost information
regarding
anesthesia provider
administration of
sedation
Adherence to
HIPAA guidelines

Activities

Output

Outcome-Short

Literature review
to determine
sedation practices
in GI endoscopy
suite

Results of
statistical analysis
of difference in
sedation methods

Discharge times
from PACU after
colonoscopy
decreased

Cost savings
regarding
medication
administration

Adaptation of new
flow in GI
endoscopy suite

Statistical analysis
of different
sedation methods
to determine of
significance is
present
Presentation to
gastroenterologists
regarding costsavings potential
by administration
of propofol for
sedation

Cost of anesthesia
provider
administration of
sedation versus
RN administration

OutcomeIntermediate
Use of propofol
exclusively for
sedation for
colonoscopies in
GI endoscopy suite
Costs reduced for
GI department

Change in attitudes Costs reduced for
of GI staff about
patients
sedation practices
undergoing
colonoscopy

Outcome-Long
Term
Sedation practice
change
implemented
Propofol
implemented for
sedation for EGDs
in the GI
endoscopy suite
Budget improved
for GI department
due to savings
from colonoscopy
sedation
Patient satisfaction
improved

APPENDIX D – SWOT Analysis

•

Strengths
No cost for the facility where
project will be conducted
Retrospective chart review

•
•
•
•
•

Opportunities
Increase revenue for the facility
Decrease costs for the patient
Increase patient satisfaction
Improve patient safety
Engage providers in EBP

•

•
•
•
•
•
•
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Weaknesses
Only patients ASA I or II included
Unable to control variables
Documentation errors may be
present
Threats
Disinterest by gastroenterologists
performing colonoscopies
Disinterest by administration of the
organization
Cost for administration of propofol
by anesthesia providers outweighs
savings from decreased time until
discharge from PACU

APPENDIX E – ASA PS Classification
Table A2.
ASA Physical Status Classification

ASA PS Classification
ASA I
ASA II
ASA III
ASA IV
ASA V
ASA VI

E

Description
A normal healthy patient.
A patient with mild systemic disease.
A patient with severe systemic disease.
A patient with severe systemic disease that
is a constant threat to life.
A moribund patient who is not expected to
survive without the operation.
A declared brain-dead patient whose
organs are being removed for donor
purposes.
Emergency surgery

(American Society of Anesthesiologists, 2014)
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APPENDIX F – Data Collection Tool

APPENDIX F- DATA COLLECTION TOOL
Identification # _______________
Procedure Date _______________

Age _______________

Sex ______________

ASA classification _____________
PMH:

Home Medications:

Allergies:

Type of Sedation: Moderate Sedation or MAC

Sedation start time

Procedure start time

Sedation end time

Total time
(minutes)

Procedure end time

Total time (minutes)

PACU start time

PACU discharge time

Total time (minutes)

Procedure end time

PACU discharge time

Total time (minutes)
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APPENDIX G – Data Collection Tool- Cost Analysis
Cost for sedation procedure: moderate
sedation
Cost for sedation procedure: MAC by
anesthesia providers
Cost of 50ml vial of propofol:
Cost of 2ml vial of midazolam:
Cost of 2ml vial of fentanyl:
Cost of 50mg vial of meperidine:
Cost of other medication (please specify):
Cost of other medication (please specify):
Reimbursement for colonoscopies:
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APPENDIX H – IRB Approval
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APPENDIX I – Letter of Support
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